PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Feds fund research that could slash US cancer deaths by 50%

ARPA-H fast-tracks development of new cancer implant technology

Feds fund research that could slash US cancer deaths by 50%
2023-09-26
(Press-News.org) HOUSTON – (Sept. 26, 2023) – The Advanced Research Projects Agency for Health (ARPA-H) has awarded $45 million to rapidly develop sense-and-respond implant technology that could slash U.S. cancer-related deaths by more than 50%.

The award to a Rice University-led team of researchers from seven states will fast-track development and testing of a new approach to cancer treatment that aims to dramatically improve immunotherapy outcomes for patients with ovarian, pancreatic and other difficult-to-treat cancers.

“Instead of tethering patients to hospital beds, IV bags and external monitors, we’ll use a minimally invasive procedure to implant a small device that continuously monitors their cancer and adjusts their immunotherapy dose in real time,” said Rice bioengineer Omid Veiseh, principal investigator (PI) on the ARPA-H cooperative agreement. “This kind of ‘closed-loop therapy’ has been used for managing diabetes, where you have a glucose monitor that continuously talks to an insulin pump. But for cancer immunotherapy, it’s revolutionary.”

Rice President Reginald DesRoches said, “Rice is proud to be the recipient of the second major funding award from the ARPA-H, a new funding agency established last year to support research that catalyzes health breakthroughs. The research Rice bioengineer Omid Veiseh is doing in leading this team is truly groundbreaking and could potentially save hundreds of thousands of lives each year. This is the type of research that makes a significant impact on the world.”

The team includes engineers, physicians and multidisciplinary specialists in synthetic biology, materials science, immunology, oncology, electrical engineering, artificial intelligence and other fields spanning 20 different research labs. The project and team are named THOR, an acronym for “targeted hybrid oncotherapeutic regulation.” THOR’s implant, or “hybrid advanced molecular manufacturing regulator,” goes by the acronym HAMMR.

Dr. Amir Jazaeri, a co-PI and professor of gynecologic oncology at the University of Texas MD Anderson Cancer Center, summarized the clinical need and potential of the technology as follows: “Cancer cells are continually evolving and adapting to therapy. However, currently available diagnostic tools, including radiologic tests, blood assays and biopsies, provide very infrequent and limited snapshots of this dynamic process. As a result, today’s therapies treat cancer as if it were a static disease. We believe THOR could transform the status quo by providing real-time data from the tumor environment that can in turn guide more effective and tumor-informed novel therapies.”

The THOR team includes 19 co-PIs from Rice, MD Anderson, Georgia Institute of Technology, Stanford University, Carnegie Mellon University, Northwestern University, the University of Houston, Johns Hopkins University, the Chicago-based startup CellTrans and New York City-based Bruder Consulting and Venture Group.

The THOR cooperative agreement includes funding for a first-phase clinical trial of HAMMR for the treatment of recurrent ovarian cancer. The trial is slated to begin in the fourth year of THOR’s 5 1/2-year project.

“The technology is broadly applicable for peritoneal cancers that affect the pancreas, liver, lungs and other organs,” said Veiseh, an associate professor of bioengineering at Rice and a CPRIT Scholar with the Cancer Prevention and Research Institute of Texas. “The first clinical trial will focus on refractory recurrent ovarian cancer, and the benefit of that is that we have an ongoing trial for ovarian cancer with our encapsulated cytokine ‘drug factory’ technology. We'll be able to build on that experience. We have already demonstrated a unique model to go from concept to clinical trial within five years, and HAMMR is the next iteration of that approach.”

The THOR award will be administered through the Rice Biotech Launch Pad, a new medical innovation and commercialization initiative. Directed by Veiseh, the initiative aims to rapidly turn Rice-discovered technologies into medical treatments that cure diseases and improve lives.

THOR is the second program funded under ARPA-H’s inaugural Open Broad Agency Announcement solicitation for research proposals. The first is a $24 million project to boost immune cell function led by Emory University that was awarded Aug. 23.

-30-

Video:

https://youtu.be/FruCjsGvCsg
DESCRIPTION: Funded by a $45 million grant from the Advanced Research Projects Agency for Health, or ARPA-H, the THOR Project is a first-of-its-kind approach to cancer treatment that aims to dramatically improve immunotherapy outcomes for patients with ovarian, pancreatic and other difficult-to-treat cancers. (Video by Brandon Martin/Rice University)

Image downloads:

https://news-network.rice.edu/news/files/2023/09/0925_THOR-053BMar-hammr-lg.jpg
CAPTION: A prototype of the “hybrid advanced molecular manufacturing regulator,” or HAMMR, a “closed-loop,” drug-producing implant smaller than an adult’s finger that is being developed to treat ovarian, pancreatic and other difficult-to-treat cancers. The implant, which is small enough to be implanted with minimally invasive surgery, will be able to  continuously monitor a patient’s cancer and adjust their immunotherapy dose in real time. It is under development by a Rice University-led team of researchers from eight universities and two companies in seven states and is supported by a $45 million award from the Advanced Research Projects Agency for Health that includes funding for a first-phase clinical trial for recurrent ovarian cancer within five years. (Photo by Brandon Martin/Rice University)

https://news-network.rice.edu/news/files/2023/09/0925_THOR-HAMMR-fig-lg.jpg
CAPTION: A figure illustrating how a “closed-loop” implant called HAMMR (short for “hybrid advanced molecular manufacturing regulator”) will be used to treat recurrent ovarian cancer. The implant, which is small enough to be implanted with minimally invasive surgery, is being developed by a Rice University-led team of researchers from eight universities and two companies in seven states. The Advanced Research Projects Agency for Health awarded $45 million to fast-track development of the implant, which includes funding for a first-phase clinical trial within five years. (Figure courtesy of Veiseh Lab/Rice University)

https://news-network.rice.edu/news/files/2023/09/0925_THOR-ajov222bm-lg2k.jpg
CAPTION: Omid Veiseh (right) and Amir Jazaeri in Veiseh’s Rice University laboratory in August 2023. Veiseh is principal investigator on the “targeted hybrid oncotherapeutic regulation” (THOR) project, a $45 million program that the Advanced Research Projects Agency for Health (ARPA-H) is funding to fast-track the development of a small implant that can continuously monitor a patient’s cancer and adjust their immunotherapy dose in real time. Veiseh is an associate professor of bioengineering at Rice and a CPRIT Scholar with the Cancer Prevention and Research Institute of Texas. Jazaeri, a THOR co-principal investigator, is a professor of gynecologic oncology at the University of Texas MD Anderson Cancer Center, vice chair for clinical research in MD Anderson’s Department of Gynecologic Oncology and Reproductive Medicine and director of MD Anderson’s Gynecologic Cancer Immunotherapy Program. (Photo by Brandon Martin/Rice University)

https://news-network.rice.edu/news/files/2023/09/0925_THOR-0119Bmar156-Veiseh-lg.jpg
CAPTION: Omid Veiseh, an associate professor of bioengineering at Rice University, is the principal investigator on the THOR Project. Short for “targeted hybrid oncotherapeutic regulation,” THOR is a $45 million program by the Advanced Research Projects Agency for Health (ARPA-H) to fast-track development of a small implant that can continuously monitor a patient’s cancer and adjust their immunotherapy dose in real time. (Photo by Brandon Martin/Rice University)

Related stories:

​​​​​​Rice Biotech Launch Pad accelerator aims to rapidly turn medical and health discoveries into cures – Sept. 12, 2023
https://news.rice.edu/news/2023/rice-biotech-launch-pad-accelerator-aims-rapidly-turn-medical-and-health-discoveries

‘Drug factory’ implants eliminate mesothelioma tumors in mice – Aug. 22, 2022
news.rice.edu/news/2022/drug-factory-implants-eliminate-mesothelioma-tumors-mice

Rice lab’s ‘drug factory’ implants cleared for human trials – Aug. 3, 2022
news.rice.edu/news/2022/rice-labs-drug-factory-implants-cleared-human-trials

‘Drug factory’ implants eliminate ovarian, colorectal cancer in mice – March 2, 2022
news.rice.edu/news/2022/drug-factory-implants-eliminate-ovarian-colorectal-cancer-mice

THOR investigators:

Omid Veiseh* - Rice University

Isaac Hilton - Rice University

Laura Segatori - Rice University

Oleg Igoshin - Rice University

Jacob Robinson - Rice University

Jonathan Rivnay - Northwestern University

Shana Kelley - Northwestern University

Tzahi Cohen-Karni - Carnegie Mellon University

Rahul Panat - Carnegie Mellon University

Douglas Weber - Carnegie Mellon University

Josiah Hester - Georgia Institute of Technology

Yingyan Lin - Georgia Institute of Technology

Ken Chen - MD Anderson Cancer Center

Amir Jazaeri - MD Anderson Cancer Center

Nathan Reticker-Flynn - Stanford University

Jamie Spangler - Johns Hopkins University

Weiyi Peng - University of Houston

Susan Drapeau - Bruder Consulting

José Oberholzer - Cell Trans

*Principal investigator

Links:

ARPA-H: arpa-h.gov

Veiseh lab: veisehlab.rice.edu

Rice Biotech Launch Pad: biotechlaunchpad.rice.edu

Rice Bioengineering: bioengineering.rice.edu

George R. Brown School of Engineering: engineering.rice.edu

This release can be found online at news.rice.edu.

Follow Rice News and Media Relations via Twitter @RiceUNews.

Located on a 300-acre forested campus in Houston, Rice University is consistently ranked among the nation’s top 20 universities by U.S. News & World Report. Rice has highly respected schools of Architecture, Business, Continuing Studies, Engineering, Humanities, Music, Natural Sciences and Social Sciences and is home to the Baker Institute for Public Policy. With 4,240 undergraduates and 3,972 graduate students, Rice’s undergraduate student-to-faculty ratio is just under 6-to-1. Its residential college system builds close-knit communities and lifelong friendships, just one reason why Rice is ranked No. 1 for lots of race/class interaction and No. 4 for quality of life by the Princeton Review. Rice is also rated as a best value among private universities by Kiplinger’s Personal Finance.

END


[Attachments] See images for this press release:
Feds fund research that could slash US cancer deaths by 50% Feds fund research that could slash US cancer deaths by 50% 2 Feds fund research that could slash US cancer deaths by 50% 3

ELSE PRESS RELEASES FROM THIS DATE:

Thiol ligands modify metal nanocluster structures and optical properties

Thiol ligands modify metal nanocluster structures and optical properties
2023-09-26
Metal nanoclusters are tiny, crystalline structures up to two nanometers (2 x 10-9 meters) in diameter that contain a few to hundreds of metal atoms.  Understanding the precise assembly of metal nanoclusters is paramount to determining how different structures affect the properties and molecular interactions of these materials.  Researchers recently synthesized two similar gold-silver (Au9Ag6) nanoclusters in a highly controlled manner to determine the precise atomic structure of each nanocluster and the effects of specific thiol ligands, or sulfur-containing binding molecules, on material synthesis.   Given their extremely small size, metal nanoclusters have ...

Researchers build and test a framework for achieving climate resilience across diverse fisheries

Researchers build and test a framework for achieving climate resilience across diverse fisheries
2023-09-26
(Santa Barbara, Calif.) — What makes for a successful climate-resilient fishery, one that sustainably produces resources for human benefit despite increasing climate stressors and human impacts? It’s a question that faces present and future fisheries, their practitioners and fishing communities as the world turns to the ocean to feed its growing population.   “For a fishery to be resilient it needs to be able to prepare for, resist, cope with, recover from, or adapt to any given impact,” said Jacob Eurich, who is a research associate at UC Santa Barbara’s Marine Science Institute, and a fisheries scientist at the Environmental Defense Fund (EDF). “In ...

Radiologists outperformed AI in identifying lung diseases on chest X-ray

Radiologists outperformed AI in identifying lung diseases on chest X-ray
2023-09-26
OAK BROOK, Ill. – In a study of more than 2,000 chest X-rays, radiologists outperformed AI in accurately identifying the presence and absence of three common lung diseases, according to a study published in Radiology, a journal of the Radiological Society of North America (RSNA). “Chest radiography is a common diagnostic tool, but significant training and experience is required to interpret exams correctly,” said lead researcher Louis L. Plesner, M.D., resident radiologist and Ph.D. fellow in the Department of Radiology at Herlev and Gentofte Hospital in Copenhagen, Denmark. While commercially available ...

SwRI, UTSA collaborate to detect traumatic brain injury through breath analysis

2023-09-26
SAN ANTONIO — September 26, 2023—Researchers from Southwest Research Institute (SwRI) and The University of Texas at San Antonio (UTSA) are developing techniques to detect traumatic brain injury (TBI) by analyzing breath for specific biomarkers. The project, led by SwRI’s Dr. Mark Libardoni and UTSA’s Dr. Marzieh Memar and Dr. Morteza Seidi, is supported by a $125,000 grant from the Connecting through Research Partnerships (Connect) program. Breath analysis is performed by analyzing exhaled breath for specific biomarkers, such as metabolites, proteins and ...

Projects launch to map brain connections in mouse and macaque

Projects launch to map brain connections in mouse and macaque
2023-09-26
A complete map of all the connections in an entire mammalian brain may be in sight. Allen Institute researchers have just launched three new projects to construct large, detailed maps of neuronal connections in sections of the mouse and macaque brains, with an eye toward creating full wiring diagrams of these animals’ brains in the future. These projects are funded by the National Institutes of Health’s Brain Research Through Advancing Innovative Neurotechnologies® (BRAIN) Initiative. Allen Institute research teams ...

National Science Foundation research award will expand the shift+OPEN initiative from the MIT Press

National Science Foundation research award will expand the shift+OPEN initiative from the MIT Press
2023-09-26
The MIT Press is delighted to announce that it has received a two-year, $275,000 Early-Concept Grant for Exploratory Research (EAGER) from the National Science Foundation to expand the shift+OPEN initiative and shift at least two more journals to diamond open access. The Press will also use the grant to assess and compare the viability of open access models for advancing and sustaining the outputs of scientific and scholarly STEM and HSS research.  “We’re grateful to the National Science Foundation for their support of our growing shift+OPEN program,” says Nick Lindsay, Director for Journals and Open Access for the MIT ...

New report shows Food is Medicine interventions would save U.S. lives and billions of dollars

New report shows Food is Medicine interventions would save U.S. lives and billions of dollars
2023-09-26
Incorporating targeted food and nutrition strategies into healthcare on a national level will improve health and quality of life, reduce work for hospitals, and cut healthcare costs, according to experts studying Food is Medicine (FIM) efforts. The health and economic benefits of this approach are detailed in a report out today from researchers at the Food is Medicine Institute at the Friedman School of Nutrition Science and Policy at Tufts University, through support from The Rockefeller Foundation. The True Cost of Food: Food is Medicine Case Study quantifies the potential health and economic benefits of FIM efforts, which refer to food-based nutrition ...

The Giant Magellan Telescope’s final mirror fabrication begins

The Giant Magellan Telescope’s final mirror fabrication begins
2023-09-26
PASADENA, CA — September 26, 2023 — The Giant Magellan Telescope begins the four-year process to fabricate and polish its seventh and final primary mirror, the last required to complete the telescope’s 368 square meter light collecting surface, the world’s largest and most challenging optics ever produced. Together, the mirrors will collect more light than any other telescope in existence, allowing humanity to unlock the secrets of the Universe by providing detailed chemical analyses of celestial objects and their origin.   Last week, the University of Arizona Richard F. Caris Mirror Lab closed the lid on nearly 20 tons of the ...

Fabrication of p-type 2D single-crystalline transistor arrays with Fermi-level-tuned van der Waals semimetal electrodes

Fabrication of p-type 2D single-crystalline transistor arrays with Fermi-level-tuned van der Waals semimetal electrodes
2023-09-26
Professor Soon-Yong Kwon in the Department of Materials Science and Engineering and the Graduate School of Semiconductor Materials and Devices Engineering at UNIST, in collaboration with Professor Zonghoon Lee, has embarked on a pioneering research endeavor focusing on the development of high-performance p-type semiconductor devices, utilizing molybdenum ditelluride (MoTe2)—a compound renowned for its unique properties. This pioneering technology holds great promise for application in the next-generation complementary metal oxide semiconductor (CMOS) industry, where ultrafine technology is crucial. CMOS ...

Tailored text messages not enough to improve mobility after heart issues

2023-09-26
Nearly one in three Americans wear a wearable device, like a smartwatch, to track their health and fitness. Studies have shown positive effects of increasing movement in ways that can be measured by these devices, especially for people who recently had a heart attack or other cardiovascular event. But a Michigan Medicine-led report shows that adding a mobile health application to such devices yields mixed results. Tailored text messages to encourage high-risk people to move more may improve some short-term outcomes but doesn’t always improve physical activity levels for everyone.   The ...

LAST 30 PRESS RELEASES:

Time alone heightens ‘threat alert’ in teenagers – even when connecting on social media

Study challenges long-held theories on how migratory birds navigate 

Unlocking the secrets of ketosis

AI analysis of PET/CT images can predict side effects of immunotherapy in lung cancer

Making an impact. Research studies a new side of helmet safety: faceguard failures

Specific long term condition combinations have major role in NHS ‘winter pressures’

Men often struggle with transition to fatherhood amid lack of targeted information and support

More green space linked to fewer preventable deaths in most deprived areas of UK

Immunotherapy drug pembrolizumab improves outcomes for patients with soft tissue sarcoma

A formula for life? New model calculates chances of intelligent beings in our Universe and beyond

Could a genetic flaw be the key to stopping people craving sugary treats?

Experts urge complex systems approach to assess A.I. risks

Fossil fuel CO2 emissions increase again in 2024

Winners of Applied Microbiology International Horizon Awards 2024 announced

A toolkit for unraveling the links between intimate partner violence, trauma and substance misuse

Can everyday physical activity improve cognitive health in middle age?

Updated guidance reaffirms CPR with breaths essential for cardiac arrest following drowning

Study reveals medical boards rarely discipline physician misinformation

New treatment helps children with rare spinal condition regain ability to walk

'Grow Your Own' teacher prep pipeline at the University of Louisiana at Lafayette funded by US Department of Education

Lab-grown human immune system uncovers weakened response in cancer patients

More than 5 million Americans would be eligible for psychedelic therapy, study finds

Children’s Hospital of Philadelphia researchers find community health workers play critical role in coordinating asthma care across home, school and community

Comprehensive Genomic Profiling leads to better patient outcomes, new joint study says  

Animated movie characters with strabismus are more likely to be villains, study finds

How retailers change ordering strategy when a supplier starts its own direct channel

Young coral use metabolic tricks to resist bleaching

Protecting tax whistleblowers pays off

Bioluminescent proteins made from scratch enable non-invasive, multi-functional biological imaging

New study links air pollution with higher rates of head and neck cancer

[Press-News.org] Feds fund research that could slash US cancer deaths by 50%
ARPA-H fast-tracks development of new cancer implant technology